Should sulfonylurea be discontinued or maintained at the lowest dose when starting ipragliflozin? A multicenter observational study in Japanese patients with type 2 diabetes

AIMS/INTRODUCTION: We investigated the difference in efficacy and safety between discontinuation and maintaining of sulfonylurea when adding a sodium–glucose cotransporter 2 inhibitor. MATERIALS AND METHODS: In the present multicenter, prospective observational study, 200 patients with type 2 diabet...

詳細記述

保存先:
書誌詳細
出版年:J Diabetes Investig
主要な著者: Takahashi, Kiyohiko, Cho, Kyu Yong, Nakamura, Akinobu, Miya, Aika, Miyoshi, Arina, Yamamoto, Chiho, Nomoto, Hiroshi, Niwa, Hirokatsu, Takahashi, Kiyohito, Manda, Naoki, Kurihara, Yoshio, Aoki, Shin, Ito, Yoichi M, Atsumi, Tatsuya, Miyoshi, Hideaki
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley and Sons Inc. 2018
主題:
Articles
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6400155/
https://ncbi.nlm.nih.gov/pubmed/30136403
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12913
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料